TARA ROA: Open Payments
NPI 1043286933 · HAYS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 16 payments from 11 companies in 2025. Trend: 2023 $286 · 2024 $574 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| CeQur Corporation | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Insulet Corporation | 1 | $19 |
Products named: Kerendia, OTEZLA, GIVLAARI, CeQur Simplicity, JARDIANCE, MOUNJARO, GEMTESA, LEQVIO.
Industry payments across KS — which companies pay providers there.
